Clinical and Translational Research
Copyright ©The Author(s) 2020.
World J Clin Cases. Feb 26, 2020; 8(4): 658-669
Published online Feb 26, 2020. doi: 10.12998/wjcc.v8.i4.658
Table 2 Characteristics of 30 gastric signet ring cell carcinoma and 30 adenocarcinoma patients, n (%)
CharacteristicOverall (n = 60)GSRCC (n = 30)Adenocarcinoma (n = 30)P value
Age (yr)0.052
≤ 6541 (68.3)24 (80.0)17 (56.7)
> 6519 (31.7)6 (20.0)13 (43.3)
Gender0.584
Male40 (66.7)21 (70.0)19 (63.3)
Female20 (33.3)9 (30.0)11 (36.7)
Tumor size (cm)0.584
≤ 540 (66.7)21 (70.0)19 (63.3)
> 520 (33.3)9 (30.0)11 (36.7)
Lauren type0
Intestinal12 (20.0)0 (0)12 (40.0)
Diffuse35 (58.3)26 (86.7)9 (30.0)
Mixed12 (20.0)4 (13.3)8 (26.7)
Unknown1 (1.67)0 (0)1 (3.3)
Histology differentiation0.038
Poorly/un-differentiated56 (93.3)30 (100.0)26 (86.7)
Well/moderately differentiated4 (6.7)0 (0)4 (13.3)
Unknown
T stage0.725
T15 (8.3)3 (10.0)2 (6.7)
T29 (15.0)3 (10.0)6 (20.0)
T312 (20.0)6 (20.0)6 (20.0)
T434 (56.7)18 (60.0)16 (53.3)
N stage0.639
N016 (26.7)8 (26.7)8 (26.7)
N16 (10.0)3 (10.0)3 (10.0)
N220 (33.3)8 (26.7)12 (40.0)
N318 (30.0)11 (36.7)7 (23.3)
M stage0.15
Metastasis2 (3.3)2 (6.7)0 (0)
No metastasis58 (96.7)28 (93.3)30 (100.0)
Positive lymph nodes0.39
≤ 843 (71.7)20 (66.7)23 (76.7)
> 817 (28.3)10 (33.3)7 (23.3)
Lymphovascular invasion0.355
Yes31 (51.7)15 (50.0)16 (53.3)
No27 (45.0)13 (43.3)14 (46.7)
Unknown2 (3.3)2 (6.7)0 (0)
Nerve invasion0.213
Yes42 (70.0)22 (73.3)20 (66.7)
No16 (26.7)6 (20)10 (33.3)
Unknown2 (3.3)2 (6.7)0 (0)
Neoadjuvant chemotherapy0.688
Yes7 (88.3)4 (13.3)3 (10.0)
No53 (11.7)26 (86.7)27 (90.0)